Inhibitors of Type II NADH:menaquinone Oxidoreductase Represent a Class of Antitubercular Drugs

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.0500469102
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Kinase Inhibitors: A New Class of Antirheumatic Drugs

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2012English

Steady-State Kinetics and Inhibitory Action of Antitubercular Phenothiazines onMycobacterium tuberculosisType-II NADH-Menaquinone Oxidoreductase (NDH-2)

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Tuberculosis After Gastrectomy, Plasmatic Concentration of Antitubercular Drugs

Mediterranean Journal of Hematology and Infectious Diseases
Infectious DiseasesHematology
2012English

New Antitubercular Drugs Designed by Molecular Modification

2012English

Synthetic Inhibitors of Ras Palmitoylation: Defining a Novel Class of Drugs Targeting Breast Cancers

2004English

Synergistic Interactions of MmpL3 Inhibitors With Antitubercular Compounds in Vitro

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

L-Type Calcium Channel Gating Modifiers as a New Class of Antiarrhythmic Drugs

Biophysical Journal
Biophysics
2018English

A New Class of Antidepressant Drugs in the Treatment of Psychiatric Disorders: The Triple Reuptake Inhibitors

2011English

Class II and IV HDACs Function as Inhibitors of Osteoclast Differentiation

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy